Skip to main content

Education/ACR/EULAR

ACR20 Jefferson Memorial

ACR Urges CMS to Reconsider Copay Assistant Programs in CMS Proposed Rule

Feb 01, 2023

The Health and Human Services Notice of Benefit and Payment Parameters proposed rule for 2024 does not revise policies related to copay assistance and patient deductibles.



 The American College of Rheumatology (ACR) today submitted comments to Centers for Medicare and Medicaid

Read Article
AI Passes U.S. Medical Licensing Exam Two artificial intelligence (AI) programs -- including ChatGPT -- have passed the U.S. Medical Licensing Examination (USMLE), according to two recent papers. https://t.co/E5GEWrJR00 https://t.co/nd9PrLVn4U
RheumNow Podcast square

Simon Says “Don’t Do This” (1.27.2022)

Jan 27, 2023

Dr. Jack Cush reviews this week’s journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything.




  1. "Dry Synovitis" exist in juvenile arthritis pts? Study of 12 DS pts, says its different from Poly #JIA; onset 6.1 yrs

Read Article
overlap,heart

Rheumatic Disease - IBD Overlap

MedPage Today
Jan 26, 2023

Nearly one in 10 patients with inflammatory bowel disease (IBD) also have rheumatologic disorders, meaning that specialists have to talk to each other to develop a treatment plan that works for both conditions, a researcher suggested.



Of 228 IBD patients treated in the clinic, 9.2%

Read Article
AI.think_.brain_.jpg

AI Passes U.S. Medical Licensing Exam

MedPage Today
Jan 26, 2023

Two artificial intelligence (AI) programs -- including ChatGPT -- have passed the U.S. Medical Licensing Examination (USMLE), according to two recent papers.



The papers highlighted different approaches to using large language models to take the USMLE, which is comprised of three exams

Read Article
Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.https://t.co/RaFKTqhQjN https://t.co/hH0NcpOoyx
rare

VEXAS may be more common than expected

Jan 25, 2023

A great study of a recently described rheumatologic/hematologic disorder VEXAS (vacuoles, E1-ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) syndrome recently appeared in JAMA, describing the frequency and presentations of UBA1 variant. 

Read Article
OA,biomarker

Blood Test Identifies Osteoarthritis Progression

EurekAlert!
Jan 25, 2023

A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods, providing an important tool to advance research and speed discovery of new therapies.



The test relies on a biomarker and fills an important void in medical research for

Read Article
Burden of BMI on Costs of Musculoskeletal Diseases A cross-sectional global study shows a substantial impact of obesity and BMI on the health and economic impact of patients with musculoskeletal (MSK) disorders. https://t.co/EZJTnLeaOZ https://t.co/sAOQ3fuq8Z
knee.surg2_.jpg (keep)

Periprosthetic Joint Infections

Jan 23, 2023

Recent NEJM has reviewed arthroplasty-associated infection and periprosthetic joint infections (PJI), noting this is a rare event; notably these infections are caused by skin microorganisms introduced during arthroplasty surgery or may be seeded post-surgically, via hematogenously spread or

Read Article
Scale,weight

Burden of BMI on Costs of Musculoskeletal Diseases

Jan 23, 2023

A cross-sectional global study shows a substantial impact of obesity and BMI on the health and economic impact of patients with musculoskeletal (MSK) disorders.



In this cross-sectional study of 192 countries and territories, 7.3 million years lived with disability and $180.7 billion

Read Article
RheumNow Podcast square

PsA Til Death Do Us Part (1.20.2023)

Jan 20, 2023

Dr. Jack Cush reviews the highlights from the past week on RheumNow.com.

Read Article
New Guideline: Vaccinations OK for Rheum Patients Nearly all available vaccines can be given to people w/ rheumatologic diseases, according to a new guideline from the ACR, though the timing for their administration and dosing may need adjustment.https://t.co/kHWyrmjkuw https://t.co/LrcFrZR2TO
vaccination

New Guideline: Vaccinations OK With Few Tweaks for Rheum Patients

Jan 17, 2023

Nearly all available vaccines can be given to people with rheumatologic diseases, according to a new, detailed guideline from the American College of Rheumatology (ACR), though the timing for their administration and dosing of antirheumatic drugs may need adjustment in some cases.



Read Article
Join RheumNow Live in person or virtually on 3/18 and 3/19. This meeting is unlike any other meeting you attended. But don't take our word for it, last year's attendees say: "Great conference. Best in the last year. I did Hopkins, CCR, and ACR too"https://t.co/Im6xStFwOw https://t.co/NhdbkNo1jl
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update https://t.co/CmYnENB60W https://t.co/Qm5hR1fCx6
RheumNow Podcast square

Rheum Believe it Or Not (1.13.2023)

Jan 13, 2023

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January.  Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.  Here are the links below.




  1. ACR GCA classification criteria tested in 676

Read Article
2022 Memorium Sadly, too many of our rheumatology colleagues passed on in 2022. Here is an (incomplete) list of notable brethren, mentors, do-gooders and great rheumatologists.https://t.co/wtr4ablgUm https://t.co/xPpgnrEQWz
Remibrutinib in Sjogren's Syndrome Dr. Michael Putman reports on abstract 1113 presented at ACR22. Abstract 1113: Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Studyhttps://t.co/4UAxMq2z0X https://t.co/kzinfgDGZr
For 2023 - what you going to focus on with your patients? Same ole, same ole means youre not getting better. How about focusing on 2 main messages, mine would be patient "STRENGTH" and "COMPLIANCE" (meaning more Rx education) https://t.co/fEIVYk6Z9m
ACP Recommends Bisphosphonates as Initial Therapy for Osteoporosis The guideline is based on a systemic review and network meta-analysis conducted by the ACP Center for Evidence Reviews at the Portland Veteran Affairs Research Foundation. https://t.co/Tx6PnpCEOp https://t.co/AVsnC1yubI
Join us for RheumNow Live this March 18-19 in Dallas, TX! We're not like other meetings--we're answering the questions you want answered. RNL is a meeting to engage your mind and change your practice. Join us in-person or virtually!https://t.co/bMphD12Bie https://t.co/Hx0uHAIUWd
reflections,ripple

2022 Memorium

Jan 06, 2023

Sadly, too many of our rheumatology colleagues passed on in 2022. Here is an (incomplete) list of notable brethren, mentors, do-gooders and great rheumatologists:

Read Article
RheumNow Podcast square

2022 Rheumatology Year in Review (1-6-2023)

Jan 06, 2023

Dr. Jack Cush reviews the best of 2022 in Rheumatology - highlights on new drug indications, breakthrough lupus therapies, new biosimilars and the multivitamin letdown.

Read Article
2022,wordle

2022 Rheumatology Year in Review

Jan 05, 2023

2022 was a year of recovery, discovery, and some losses.  While still dealing with the aftermath of COVID-19, rheumatologists were resilient as leaders for their patients and research in advancing rheumatologic care.

Read Article
×